US Bioservices Corporation
16750 Westgrove Drive, Suite 100
10 articles with US Bioservices Corporation
Patients using AdhereTech Smart Pill Bottles through US Bioservices stayed on therapy longer, refilled prescriptions more frequently
DIACOMIT® is approved by the FDA in two formulations – capsules and powder for oral suspension.
US Bioservices Selected by Bayer and Its Collaboration Partner Loxo Oncology, Inc. to Dispense Vitrakvi® (larotrectinib)
New therapy approved to treat gene fusions across several different types of tumors
US Bioservices, a specialty pharmacy that is a part of AmerisourceBergen, today announced that it has been selected by Verastem OncologyTM to dispense COPIKTRA™ (duvelisib) capsules.
US Bioservices Selected by Alnylam Pharmaceuticals as a Specialty Pharmacy Partner for ONPATTRO™ (patisiran)
Specialty pharmacy to support bringing new FDA-approved medicine to patients
US Bioservices Selected by Array BioPharma Inc to Dispense Combination Therapy for BRAF-mutant Advanced Melanoma
New FDA-approved therapy offers more options to patients with advanced type of skin cancer.
US Bioservices Selected by Rigel Pharmaceuticals, Inc. to Dispense TAVALISSE™ (fostamatinib disodium hexahydrate) Tablets
New therapy FDA-approved for adult patients with chronic immune thrombocytopenia
Company Expands Services to Provide Holistic Care for Hemophilia Patients and Caregivers
National Association of Specialty Pharmacy (NASP) announced the addition of healthcare veteran Kevin James, RPh, MBA to its governing board of directors
AmerisourceBergen Corporation Release: US Bioservices Corporation Receives URAC Specialty Pharmacy Accreditation